MedPath

Comparison of oral and intravenous ondansetron in the prevention of postoperative nausea and vomiting in cesarean section with spinal anesthesia

Phase 2
Conditions
ausea and vomiting.
Nausea and vomiting
Registration Number
IRCT201212162080N13
Lead Sponsor
Arak University of Medical Sciences,Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
162
Inclusion Criteria

age between 18-45 and ASA Class I and II
Exclusion criteria:
history of postoperative nausea and vomiting; history of motion sickness; history of allergy to ondansetron; more than two failure in spinal anaesthesia;
history of hyperemesis gravidarum.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea and vomiting. Timepoint: At 0, 1, 2, 4 and 6 hours after arrive to recovery. Method of measurement: Clinical assesment.;Consciousness. Timepoint: At 0, 1, 2, 4 and 6 hours after arrive to recovery. Method of measurement: Using Ramsay score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath